Total Assets Summary of PharmaEngine, Inc.

PharmaEngine, Inc.'s latest annual total assets in 2023 was 3.95 Billion TWD , down -0.32% from previous year.
PharmaEngine, Inc.'s latest quarterly total assets in 2024 Q2 was 4.21 Billion TWD , up 3.79% from previous quarter.
PharmaEngine, Inc. reported annual total assets of 3.96 Billion TWD in 2022, down -1.49% from previous year.
PharmaEngine, Inc. reported annual total assets of 4.02 Billion TWD in 2021, down -4.29% from previous year.
PharmaEngine, Inc. reported quarterly total assets of 4.06 Billion TWD for 2024 Q1, up 2.75% from previous quarter.
PharmaEngine, Inc. reported quarterly total assets of 4.05 Billion TWD for 2023 Q1, up 2.11% from previous quarter.

Annual Total Assets Chart of PharmaEngine, Inc. (2023 - 2009)

Historical Annual Total Assets of PharmaEngine, Inc. (2023 - 2009)

Year	Total Assets	Total Assets Growth
2023	3.95 Billion TWD	-0.32%
2022	3.96 Billion TWD	-1.49%
2021	4.02 Billion TWD	-4.29%
2020	4.2 Billion TWD	15.47%
2019	3.64 Billion TWD	-5.29%
2018	3.84 Billion TWD	-6.43%
2017	4.11 Billion TWD	3.83%
2016	3.95 Billion TWD	22.25%
2015	3.23 Billion TWD	9.99%
2014	2.94 Billion TWD	7.31%
2013	2.74 Billion TWD	66.57%
2012	1.64 Billion TWD	159.8%
2011	634.07 Million TWD	565.57%
2010	95.26 Million TWD	127.98%
2009	41.78 Million TWD	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	4.21 Billion TWD	3.79%
2024 Q1	4.06 Billion TWD	2.75%
2023 Q1	4.05 Billion TWD	2.11%
2023 Q3	3.89 Billion TWD	-6.65%
2023 Q4	3.95 Billion TWD	1.39%
2023 FY	3.95 Billion TWD	-0.32%
2023 Q2	4.17 Billion TWD	3.15%
2022 Q1	4.11 Billion TWD	2.22%
2022 Q3	3.91 Billion TWD	-6.89%
2022 Q4	3.96 Billion TWD	1.26%
2022 FY	3.96 Billion TWD	-1.49%
2022 Q2	4.2 Billion TWD	2.21%
2021 Q2	4.3 Billion TWD	0.88%
2021 Q3	3.9 Billion TWD	-9.28%
2021 Q4	4.02 Billion TWD	3.07%
2021 Q1	4.26 Billion TWD	1.47%
2021 FY	4.02 Billion TWD	-4.29%
2020 Q4	4.2 Billion TWD	16.04%
2020 Q3	3.62 Billion TWD	-1.9%
2020 FY	4.2 Billion TWD	15.47%
2020 Q1	3.68 Billion TWD	1.01%
2020 Q2	3.69 Billion TWD	0.41%
2019 Q3	3.68 Billion TWD	-2.82%
2019 Q4	3.64 Billion TWD	-1.14%
2019 FY	3.64 Billion TWD	-5.29%
2019 Q1	3.75 Billion TWD	-2.42%
2019 Q2	3.79 Billion TWD	1.04%
2018 Q1	4.05 Billion TWD	-1.4%
2018 Q4	3.84 Billion TWD	1.99%
2018 Q3	3.77 Billion TWD	-5.67%
2018 Q2	3.99 Billion TWD	-1.36%
2018 FY	3.84 Billion TWD	-6.43%
2017 Q1	3.83 Billion TWD	-3.25%
2017 Q4	4.11 Billion TWD	20.9%
2017 Q3	3.4 Billion TWD	-8.99%
2017 Q2	3.73 Billion TWD	-2.47%
2017 FY	4.11 Billion TWD	3.83%
2016 Q3	3.19 Billion TWD	-6.38%
2016 FY	3.95 Billion TWD	22.25%
2016 Q2	3.41 Billion TWD	6.74%
2016 Q1	3.19 Billion TWD	-1.21%
2016 Q4	3.95 Billion TWD	23.84%
2015 Q3	3.22 Billion TWD	-4.31%
2015 Q4	3.23 Billion TWD	0.32%
2015 Q2	3.37 Billion TWD	15.57%
2015 Q1	2.91 Billion TWD	-0.86%
2015 FY	3.23 Billion TWD	9.99%
2014 Q3	2.94 Billion TWD	8.84%
2014 Q2	2.7 Billion TWD	-0.68%
2014 Q1	2.72 Billion TWD	-0.85%
2014 FY	2.94 Billion TWD	7.31%
2014 Q4	2.94 Billion TWD	0.11%
2013 Q2	1.62 Billion TWD	-0.47%
2013 Q4	2.74 Billion TWD	49.29%
2013 Q3	1.83 Billion TWD	12.8%
2013 Q1	1.63 Billion TWD	-0.62%
2013 FY	2.74 Billion TWD	66.57%
2012 FY	1.64 Billion TWD	159.8%
2012 Q2	772.23 Million TWD	-0.56%
2012 Q3	1.65 Billion TWD	114.9%
2012 Q1	776.59 Million TWD	22.48%
2012 Q4	1.64 Billion TWD	-0.74%
2011 Q4	634.07 Million TWD	0.0%
2011 FY	634.07 Million TWD	565.57%
2010 FY	95.26 Million TWD	127.98%
2009 FY	41.78 Million TWD	0.0%

Peer Total Assets Comparison of PharmaEngine, Inc.

Name	Total Assets	Total Assets Difference
SYN-TECH Chem. & Pharm. Co., Ltd.	2.9 Billion TWD	-36.3%
Level Biotechnology Inc.	822.67 Million TWD	-380.619%
Sagittarius Life Science Corp	664.72 Million TWD	-494.822%
NeoCore Technology Co., Ltd.	548.74 Million TWD	-620.535%
TaiMed Biologics Inc.	3.89 Billion TWD	-1.541%
GlycoNex Incorporation	1.55 Billion TWD	-154.629%
VBI	452.1 Million TWD	-774.563%
GeneReach Biotechnology Corp.	1.17 Billion TWD	-236.177%
Taiwan Advance Bio-Pharmaceutical Inc.	748.57 Million TWD	-428.196%
Visgeneer Inc.	397.17 Million TWD	-895.508%
Mycenax Biotech Inc.	3.77 Billion TWD	-4.867%
Sunmax Biotechnology Co., Ltd.	2.15 Billion TWD	-83.134%
G&E Herbal Biotechnology Co., Ltd.	883.09 Million TWD	-347.734%
Medigen Vaccine Biologics Corporation	6.09 Billion TWD	35.103%
TaiwanJ Pharmaceuticals Co., Ltd.	73.55 Million TWD	-5275.24%
Enimmune corporation	604.82 Million TWD	-553.727%
TaiRx, Inc.	833.74 Million TWD	-374.235%
CHO Pharma, Inc.	3.08 Billion TWD	-28.123%
EirGenix Inc.	11.16 Billion TWD	64.579%
BioLASCO Taiwan Co., Ltd.	573.13 Million TWD	-589.871%
Sunny Pharmtech Inc.	1.71 Billion TWD	-130.904%
Lin BioScience, Inc.	3.59 Billion TWD	-9.931%
BioGend Therapeutics Co., Ltd.	1.05 Billion TWD	-276.391%
Feng Chi Biotech Corp.	301.03 Million TWD	-1213.455%
Bio Preventive Medicine Corp.	264.65 Million TWD	-1393.979%
Lukas Biomedical Inc.	441.19 Million TWD	-796.192%
RBC Bioscience Corporation	753.79 Million TWD	-424.539%
BiOptic Inc.	613.77 Million TWD	-544.199%
BRIM Biotechnology, Inc.	1.77 Billion TWD	-122.296%
Shine-On BioMedical Co.,Ltd.	1.15 Billion TWD	-240.939%
Great Novel Therapeutics Biotech & Medicals	644.84 Million TWD	-513.154%
Syngen Biotech Co.,Ltd.	3.1 Billion TWD	-27.289%
Anti-Microbial Savior BioteQ Co., Ltd	128.04 Million TWD	-2987.865%
SynCore Biotechnology Co.,Ltd	378.36 Million TWD	-945.01%
Genomics BioSci & Tech. Co.,Ltd.	1.13 Billion TWD	-248.718%
Neith Corporation	192.15 Million TWD	-1957.693%
Advagene Biopharma Co., Ltd.	147.93 Million TWD	-2572.759%
NaviFUS Corp.	490.53 Million TWD	-706.042%
Gwo Xi Stem Cell Applied Technology Co. , Ltd	1.22 Billion TWD	-222.58%
Sinew Pharma Inc.	1.36 Billion TWD	-190.01%
Andros Pharmaceuticals Co.,Ltd	529.14 Million TWD	-647.226%
Greenyn Biotechnology Co., Ltd	1.16 Billion TWD	-240.448%
Lumosa Therapeutics Co., Ltd.	1.65 Billion TWD	-138.723%
AP Biosciences Inc	890.75 Million TWD	-343.884%
Medigen Biotechnology Corp.	8.52 Billion TWD	53.632%
3D Global Biotech Inc.	324.14 Million TWD	-1119.788%
Pharmosa Biopharm Inc.	1.33 Billion TWD	-196.475%
Intech Biopharm Corporation	2.71 Billion TWD	-45.844%
Oneness Biotech Co., Ltd.	15.36 Billion TWD	74.265%
Eusol Biotech Co.,Ltd.	410.25 Million TWD	-863.764%
TWi Biotechnology, Inc.	396.85 Million TWD	-896.323%
Ever Supreme Bio Technology Co., Ltd	2.07 Billion TWD	-90.466%
TCI GENE Inc.	1.16 Billion TWD	-239.119%
MegaPro Biomedical Co., Ltd	294.58 Million TWD	-1242.218%
Senhwa Biosciences, Inc.	1.36 Billion TWD	-190.019%
Taiwan Bio Therapeutics Co., Ltd	941.76 Million TWD	-319.843%
NatureWise Biotech & Medicals Corporation	698.45 Million TWD	-466.098%
Savior Lifetec Corporation	3.82 Billion TWD	-3.433%
TaiGen Biopharmaceuticals Holdings Limited	1.22 Billion TWD	-221.499%
OBI Pharma, Inc.	5.6 Billion TWD	29.443%
Meribank Biotech Co., Ltd	1.06 Billion TWD	-272.306%
Acepodia, Inc.	6.81 Billion TWD	42.012%
Caliway Biopharmaceuticals Co., Ltd.	3.82 Billion TWD	-3.33%

Global Stocks Search

PharmaEngine, Inc. (4162.TWO)

Total Assets Summary of PharmaEngine, Inc.

Annual Total Assets Chart of PharmaEngine, Inc. (2023 - 2009)

Historical Annual Total Assets of PharmaEngine, Inc. (2023 - 2009)

Peer Total Assets Comparison of PharmaEngine, Inc.